General meeting
09:30
17:30
10:30
14:30
15:00
18:00
20:30
P.4. Accesses
1. AVF dysfunction: diagnosis and treatment
2. Tenckhoff catheter insertion - Medical
3. Tenckhoff catheter insertion - Surgical
P.6. Resolving cardio-renal-metabolic syndrome
1. Review of the guidelines
2. SGLT2 inhibitors: are they all the same?
3. The central role of incretin hormones
4. Cardio-renal-metabolic syndrome from the perspective of the Nephrologist
Sunday, September 15
Challenges and prospects in Nephrology
P.5. Hypertension
1. Hypertension in CKD: Evaluation and treatment
2. Hypertension on dialysis
3. Posterior reversible encephalopathy syndrome
P.7. Latest in systemic diseases
1. Lupus nephritis
2. Monoclonal gammopathies
3. Polycystic ovary disease: latest developments in diagnostic and therapeutic approaches
4. Stroke prevention in CKD
P.3. Quality of services and patient safety in Hemodialysis Units
1. The experience of the British Health System
2. The experience of the Greek Units
3. Presentation of the Unit evaluation system
D.4. Endovascular fistula creation systems
Break
D.6. The use of continuous glucose monitoring systems in people with diabetes: Basic concepts
P.8. Latest in the treatment of CKD
1. Calcimitics: their place in clinical practice
2. Goals & latest developments in the treatment of hyperphosphatemia
3. Prevention & treatment of osteoporosis
4. Latest in the treatment of uremic pruritus
P.9. Newer treatments in CKD
1. HIF-pH inhibitors
2. Latest in iron therapy
3. Newer oral anticoagulants
4. Treatment of hyperkalemia
D.7. What's new in the monitoring and treatment of IgA nephropathy
D.5. Treatment and outcome of heart failure in CKD
D.8. Atypical hemolytic uremic syndrome and TMA
SAPPHORE Hall
ERATO Hall
General meeting
12:00
12:30
Break
Break
Break
D.3. The role of renal aponeurosis in the treatment of hypertension
Expiry